AANA Journal: Buffered Lidocaine as an Ednotracheal Tube Cuff Media in Immediate Postoperative Cardiac Surgery Patients and Its Effect on Sedation Requirements

Catalog

Create Account

Availability

On-Demand

Expires on Mar 18, 2027

Cost

$0.00

Credit Offered

2 Class A Credits

2 Pharmacology Credits

Current sedative and analgesic agents used on patients that experience tracheal mucosal inflammation and irritation caused by the ETT can have negative effects on the patient, so an alternative method is needed to enhance patient comfort during intubation and decrease the need for sedative medications.

Tracheal mucosal inflammation and irritation caused by the endotracheal tube (ETT) during intubation can result in symptoms of pain and discomfort, creating challenges for patients. Various sedative and analgesic agents are used to mitigate these symptoms, however, there is concern that such medications may contribute to prolonged duration of intubation, length of intensive care unit (ICU) stay, as well as increased morbidity.

The anesthesia provider utilizes buffered lidocaine as a tool to enhance patient comfort during intubation and potentially decrease the need for sedative medications.

Learning Outcomes:

Identify how buffered lidocaine can be used as an endotracheal tube cuff media in immediate postoperative cardiac surgery patients.

Explain how buffered lidocaine can reduce symptoms and sedation requirements, improving patient comfort during intubation.

Troy Seelhammer, MD
Katelynn Kressin, RN
Ellen Borhart, RN
Darrell Schroeder, MS
Amy Amsbaugh, RRT, LRT
Jenna Steege, DNP, CRNA, APRN
Eric DuBois II, DNAP, CRNA, APRN
Erica Wittwer, PhD, MD

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.